LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Carman, Robert J.; Woodburn, Mary Alice (2011)
Publisher: Microbial Ecology in Health and Disease
Journal: Microbial Ecology in Health and Disease
Languages: English
Types: Article
Subjects:
Low levels of antibiotics in the human food chain are a public health concern. Current FDA-CVM guidelines state that the maximum amount of microbiologically active residue that may be consumed by a person in one day for life is 1.5 mg. This is called the Acceptable Daily Intake or ADI. The guidelines also suggest additional but unspecified testing of any compound for which an ADI greater than 1.5 mg/person/day is sought. We tested tetracycline (0, 0.15, 1.5 and 15 µg/mL), neomycin (0, 1.78, 17.8 and 178 µg/mL), erythromycin (0, 1.5, 15 and 150 µg/mL) and cipro┬Ćoxacin at (0, 0.43, 43, and 43 µg/mL). Based on published data of the fecal levels resulting from standard oral doses, these levels correspond to 0, 1.5, 15, 150 mg/person/d for tetracycline, neomycin and erythromycin, and 0, 0.48, 4.8 and 48 mg/person/d for ciprofloxacin. For ease of reference however, we will refer to these various challenge levels as the no-drug control and the low, medium and high doses.
  • No references.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Collected from